Essa Pharma

Developer of small molecule drugs for the treatment cancer

placeVancouver, British Columbia, Canada calendar_todayFounded 2009 groups28 employees language essapharma.com

Registered entities

Innovation

15 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,737 times.

YearFilings
20191
20204
20215
202210
20239
202410
20253

Investor mix

11 investors on record; lead investors include Deerfield, Special Situations Fund; 4 have since exited.

Investor typeCountShare
Venture capital436%
Private equity436%
Bank & private debt19%
Other / undisclosed218%
Coming soon